Skip to main content
TipRanks
Go Ultimate75% OFF

Duopharma Biotech Bhd. (7148) Income Statement

Duopharma Biotech Bhd. Income Statement

Last quarter (Q2 2026), Duopharma Biotech Bhd.'s total revenue was RM234.36M, an increase of 5.67% from the same quarter last year. In Q2, Duopharma Biotech Bhd.'s net income was RM29.87M. See Duopharma Biotech Bhd.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
RM 931.69MRM 813.70MRM 704.73MRM 696.72MRM 639.17M
RM 363.14MRM 301.54MRM 268.33MRM 279.82MRM 253.98M
RM 216.65MRM 200.89MRM 187.46MRM 187.40MRM 165.12M
Depreciation and AmortizationRM 45.62MRM 45.39MRM 43.05MRM 36.20MRM 31.95M
RM 192.11MRM 152.01MRM 124.51MRM 130.63MRM 121.91M
RM 146.49MRM 100.65MRM 80.87MRM 92.91MRM 88.76M
RM -31.58MRM -20.63MRM -17.60MRM -8.06MRM -5.78M
RM 114.91MRM 80.02MRM 63.27MRM 84.85MRM 82.98M
RM 87.46MRM 62.65MRM 52.65MRM 70.11MRM 65.68M
Per Share Metrics
Basic EPSRM 0.09RM 0.07RM 0.05RM 0.07RM 0.07
Diluted EPSRM 0.09RM 0.07RM 0.05RM 0.07RM 0.07
Weighted Average Shares Outstanding961.94M961.94M958.93M948.31M928.34M
Weighted Average Shares Outstanding (Diluted)961.94M961.94M958.93M948.31M928.34M

Currency in MYR

Duopharma Biotech Bhd. Earnings and Revenue History

0400M800M1.2B7.2 %8.4 %9.6 %10.8 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin